135 related articles for article (PubMed ID: 36386179)
1. Low FNDC5/Irisin expression is associated with aggressive phenotypes in gastric cancer.
Xu L; Ye Y; Sun Y; Zhong W; Chi L; Lin Y; Liu H; Li S; Chen H; Li C; Lin Y; Wang Q; Xue F; Lin Y
Front Pharmacol; 2022; 13():981201. PubMed ID: 36386179
[No Abstract] [Full Text] [Related]
2. Irisin/FNDC5 inhibits the epithelial-mesenchymal transition of epithelial ovarian cancer cells via the PI3K/Akt pathway.
Zhu T; Zhang W; Zhang Y; Lu E; Liu H; Liu X; Yin S; Zhang P
Arch Gynecol Obstet; 2022 Sep; 306(3):841-850. PubMed ID: 35156135
[TBL] [Abstract][Full Text] [Related]
3. The Effects of MiR-214-3p and Irisin/FNDC5 on the Biological Behavior of Osteosarcoma Cells.
Cheng G; Xu D; Chu K; Cao Z; Sun X; Yang Y
Cancer Biother Radiopharm; 2020 Mar; 35(2):92-100. PubMed ID: 32073886
[No Abstract] [Full Text] [Related]
4. Expression of Irisin/FNDC5 in Breast Cancer.
Cebulski K; Nowińska K; Jablońska K; Romanowicz H; Smolarz B; Dzięgiel P; Podhorska-Okołów M
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408891
[TBL] [Abstract][Full Text] [Related]
5. High DAPK1 Expression Promotes Tumor Metastasis of Gastric Cancer.
Wang Q; Weng S; Sun Y; Lin Y; Zhong W; Kwok HF; Lin Y
Biology (Basel); 2022 Oct; 11(10):. PubMed ID: 36290392
[TBL] [Abstract][Full Text] [Related]
6. Increased FNDC5/IRISIN protein expression in breast cancer tissue is associated with obesity in postmenopausal women.
Tejeda ME; Canto P; Tenorio-Torres A; Orozco-Arguelles L; Coral-Vázquez RM; Zentella-Dehesa A; Leal-García M; Vega-García CC; Bautista-Piña V; Méndez JP
J Clin Pathol; 2021 Jun; ():. PubMed ID: 34083413
[TBL] [Abstract][Full Text] [Related]
7. Increased FNDC5/Irisin expression in human hepatocellular carcinoma.
Gaggini M; Cabiati M; Del Turco S; Navarra T; De Simone P; Filipponi F; Del Ry S; Gastaldelli A; Basta G
Peptides; 2017 Feb; 88():62-66. PubMed ID: 28012856
[TBL] [Abstract][Full Text] [Related]
8. FNDC5/irisin facilitates muscle-adipose-bone connectivity through ubiquitination-dependent activation of runt-related transcriptional factors RUNX1/2.
He X; Hua Y; Li Q; Zhu W; Pan Y; Yang Y; Li X; Wu M; Wang J; Gan X
J Biol Chem; 2022 Mar; 298(3):101679. PubMed ID: 35124008
[TBL] [Abstract][Full Text] [Related]
9. A polymorphism in the Irisin-encoding gene (FNDC5) associates with hepatic steatosis by differential miRNA binding to the 3'UTR.
Metwally M; Bayoumi A; Romero-Gomez M; Thabet K; John M; Adams LA; Huo X; Aller R; García-Monzón C; Teresa Arias-Loste M; Bugianesi E; Miele L; Gallego-Durán R; Fischer J; Berg T; Liddle C; Qiao L; George J; Eslam M
J Hepatol; 2019 Mar; 70(3):494-500. PubMed ID: 30389552
[TBL] [Abstract][Full Text] [Related]
10. Icariin induces irisin/FNDC5 expression in C2C12 cells via the AMPK pathway.
Chen SQ; Ding LN; Zeng NX; Liu HM; Zheng SH; Xu JW; Li RM
Biomed Pharmacother; 2019 Jul; 115():108930. PubMed ID: 31055234
[TBL] [Abstract][Full Text] [Related]
11. Elevated skeletal muscle irisin precursor FNDC5 mRNA in obese OLETF rats.
Roberts MD; Bayless DS; Company JM; Jenkins NT; Padilla J; Childs TE; Martin JS; Dalbo VJ; Booth FW; Rector RS; Laughlin MH
Metabolism; 2013 Aug; 62(8):1052-6. PubMed ID: 23498898
[TBL] [Abstract][Full Text] [Related]
12. Molecular Subtypes and CD4
Ning ZK; Hu CG; Huang C; Liu J; Zhou TC; Zong Z
Front Oncol; 2020; 10():626912. PubMed ID: 33816214
[TBL] [Abstract][Full Text] [Related]
13. FNDC5/Irisin attenuates diabetic cardiomyopathy in a type 2 diabetes mouse model by activation of integrin αV/β5-AKT signaling and reduction of oxidative/nitrosative stress.
Lin C; Guo Y; Xia Y; Li C; Xu X; Qi T; Zhang F; Fan M; Hu G; Zhao H; Zhao H; Liu R; Gao E; Yan W; Tao L
J Mol Cell Cardiol; 2021 Nov; 160():27-41. PubMed ID: 34224725
[TBL] [Abstract][Full Text] [Related]
14. Exercise-linked FNDC5/irisin rescues synaptic plasticity and memory defects in Alzheimer's models.
Lourenco MV; Frozza RL; de Freitas GB; Zhang H; Kincheski GC; Ribeiro FC; Gonçalves RA; Clarke JR; Beckman D; Staniszewski A; Berman H; Guerra LA; Forny-Germano L; Meier S; Wilcock DM; de Souza JM; Alves-Leon S; Prado VF; Prado MAM; Abisambra JF; Tovar-Moll F; Mattos P; Arancio O; Ferreira ST; De Felice FG
Nat Med; 2019 Jan; 25(1):165-175. PubMed ID: 30617325
[TBL] [Abstract][Full Text] [Related]
15. FNDC5/irisin is expressed and regulated differently in human periodontal ligament cells, dental pulp stem cells and osteoblasts.
Yang Y; Pullisaar H; Landin MA; Heyward CA; Schröder M; Geng T; Grano M; Reseland JE
Arch Oral Biol; 2021 Apr; 124():105061. PubMed ID: 33508625
[TBL] [Abstract][Full Text] [Related]
16. FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise.
Huh JY; Panagiotou G; Mougios V; Brinkoetter M; Vamvini MT; Schneider BE; Mantzoros CS
Metabolism; 2012 Dec; 61(12):1725-38. PubMed ID: 23018146
[TBL] [Abstract][Full Text] [Related]
17. FNDC5 alleviates oxidative stress and cardiomyocyte apoptosis in doxorubicin-induced cardiotoxicity via activating AKT.
Zhang X; Hu C; Kong CY; Song P; Wu HM; Xu SC; Yuan YP; Deng W; Ma ZG; Tang QZ
Cell Death Differ; 2020 Feb; 27(2):540-555. PubMed ID: 31209361
[TBL] [Abstract][Full Text] [Related]
18. Interaction of CREB and PGC-1α Induces Fibronectin Type III Domain-Containing Protein 5 Expression in C2C12 Myotubes.
Yang XY; Tse MCL; Hu X; Jia WH; Du GH; Chan CB
Cell Physiol Biochem; 2018; 50(4):1574-1584. PubMed ID: 30359971
[TBL] [Abstract][Full Text] [Related]
19. FNDC5/irisin improves the therapeutic efficacy of bone marrow-derived mesenchymal stem cells for myocardial infarction.
Deng J; Zhang N; Wang Y; Yang C; Wang Y; Xin C; Zhao J; Jin Z; Cao F; Zhang Z
Stem Cell Res Ther; 2020 Jun; 11(1):228. PubMed ID: 32522253
[TBL] [Abstract][Full Text] [Related]
20. Exercise-induced myokine FNDC5/irisin functions in cardiovascular protection and intracerebral retrieval of synaptic plasticity.
Zhou X; Xu M; Bryant JL; Ma J; Xu X
Cell Biosci; 2019; 9():32. PubMed ID: 30984367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
